Difference between revisions of "Template:Antiarrhythmic agents"
Jump to navigation
Jump to search
blackwiki>Frietjes (navbox subgroup syntax update) |
blackwiki>Springbreak04 m (moved items in parentheses out to subheadings) |
||
Line 24: | Line 24: | ||
| group2 = class Ib ([[Cardiac action potential#Phase 3|Phase 3]]←) | | group2 = class Ib ([[Cardiac action potential#Phase 3|Phase 3]]←) | ||
| list2 = | | list2 = | ||
− | * ''[[Intravenous therapy|IV]]'' | + | * ''[[Intravenous therapy|IV]]'' |
− | * ''[[enteral]]'' | + | ** [[Lidocaine]]<sup>#</sup> |
− | * [[Mexiletine]] | + | * ''[[enteral]]'' |
− | * [[Tocainide]] | + | ** [[Aprindine]] |
+ | ** [[Mexiletine]] | ||
+ | ** [[Tocainide]] | ||
| group3 = class Ic ([[Cardiac action potential#Phase 0|Phase 0]]→) | | group3 = class Ic ([[Cardiac action potential#Phase 0|Phase 0]]→) | ||
Line 71: | Line 73: | ||
* [[Pindolol]] | * [[Pindolol]] | ||
* [[Propranolol]] | * [[Propranolol]] | ||
− | * ''cardioselective'' | + | * ''cardioselective'' |
− | * [[Atenolol]] | + | ** [[Acebutolol]] |
− | * [[Esmolol]] | + | ** [[Atenolol]] |
− | * [[Metoprolol]] | + | ** [[Esmolol]] |
+ | ** [[Metoprolol]] | ||
| group5 = [[adenosine A1 receptor|A<sub>1</sub> agonist]] | | group5 = [[adenosine A1 receptor|A<sub>1</sub> agonist]] |
Revision as of 03:05, 23 October 2017
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Antiarrhythmic agents|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Antiarrhythmic agents|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Antiarrhythmic agents|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.